DIPROGENTA

This brand name is authorized in Austria, Brazil, Ecuador, Estonia, Spain, Croatia, Israel, Poland, Romania, Singapore, South Africa

Active ingredients

The drug DIPROGENTA contains a combination of these active pharmaceutical ingredients (APIs):

1 Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

2 Gentamicin UNII 8X7386QRLV - GENTAMICIN SULFATE

Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits. Read about Gentamicin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DIPROGENTA Cream / Ointment	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07CC01	Betamethasone and antibiotics	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CC Corticosteroids, potent, combinations with antibiotics
Discover more medicines within D07CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 540917050029617, 540917050029717, 540917050029817, 540917050029917
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 4948-MEE-0120
Country: EE	Ravimiamet	Identifier(s): 1737389, 1856976
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 15937, 53541, 9454504, 9454504IP, 9454504IP1, 9454504IP2, 9454504IP3
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-048683132, HR-H-404715581
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1236, 1237
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100019396, 100019404, 100284253, 100292229, 100354321, 100355326, 100355349, 100357561, 100359650, 100366040, 100366063, 100379083, 100379120, 100385385, 100385669, 100396845, 100416967, 100417346, 100426842, 100440517, 100440612, 100440836, 100456988
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68115001, W68116001
Country: SG	Health Sciences Authority	Identifier(s): 01570P
Country: ZA	Health Products Regulatory Authority	Identifier(s): F/13.4.1/223, F/13.4.1/224